Depression Clinical
and Research Program

• All Current Treatment Studies
• Studies for depressed patients not taking any antidepressants
  • A Study of Omega 3-EPA vs. DHA Fatty Acids in the Treatment of Major Depression
  • A Double-Blind, Placebo-Controlled Study of the Alternative Therapy S-adenosyl-L-methionine (SAMe) versus Escitalopram in Major Depressive Disorder
  • Magnetic Resonance Scan (MRS) Study for Depressed Participants
  • Ziprasidone Augmentation Study
• Studies for depressed patients currently taking antidepressants
• Non-treatment studies
• Studies for Smoking Cessation & Relapse Prevention
• Other Studies
• Psychotherapy Studies

Magnetic Resonance Scan (MRS) Study for Depressed Participants

The purpose of this research study is to help assess the relationship between the improvement of depressive symptoms and the concentration of several compounds in the brain. This study is looking for participants who are depressed and not currently taking any medication. If eligible participants would be put on the FDA approved antidepressant medication Escitalopram (Lexapro). As part of this study there would be three MRS scans over the course of 13 weeks. These scans would take place at McLean Hospital in Belmont, MA and participants will be offered compensation for transportation to McLean Hospital as well as each scan. At the end of the study you will be offered follow up care.

If interested please contact Vicki Ameral at
617-724-9458 or vameral@partners.org

We initiate new studies regularly, so please contact us for additional information.